More Efficient Manufacturing
3× faster workflows. Massive cost reduction. Shorter expression times.
The Problem
Ex-vivo Cell Therapy is a modern miracle. But inefficient and expensive production is a travesty.
The next generation of cures need better, higher performance ways to reprogram cells.
The bottleneck isn’t discovery. It’s delivery.
The next generation of cures requires better tools — faster delivery, larger payloads, higher viability, and true industrial scale.
It’s time to stop settling.
The Solution
We’re redefining cell engineering with our high-viability, continuous-flow platform that enables fast and parallelized delivery of gene-editing payloads directly into the nucleus, regardless of cell type or payload size.
New Cures and Possibilities
Larger payload delivery directly to the nucleus.
Industrial-Ready Scale
Designed for predictable, repeatable GMP environments.
Contact
If you're developing or manufacturing cell therapies, we’d love to connect.
Thank you for your message! We'll reply shortly.